Jiang JD - Search Results

1

Inhibition of human hepatocellular carcinoma by L-proline-m-bis (2-chloroethyl) amino-L-phenylalanyl-L-norvaline ethyl ester hydrochloride (MF13) in vitro and in vivo.

Hu QY, Li JN, Song DQ, Wang YL, Bekesi G, Weisz I, Jiang JD. Hu QY, et al. Among authors: jiang jd. Int J Oncol. 2004 Nov;25(5):1289-96. Int J Oncol. 2004. PMID: 15492817

2

Inhibition of microtubule assembly in tumor cells by 3-bromoacetylamino benzoylurea, a new cancericidal compound.

Jiang JD, Wang Y, Roboz J, Strauchen J, Holland JF, Bekesi JG. Jiang JD, et al. Cancer Res. 1998 May 15;58(10):2126-33. Cancer Res. 1998. PMID: 9605756

3

Synthesis, cancericidal and antimicrotubule activities of 3-(haloacetamido)-benzoylureas.

Jiang JD, Roboz J, Weisz I, Deng L, Ma L, Holland JF, Bekesi JG. Jiang JD, et al. Anticancer Drug Des. 1998 Oct;13(7):735-47. Anticancer Drug Des. 1998. PMID: 9807159

4

The presence of HBV genomic DNA in tumor tissue correlates with P53 aberrations in human hepatocellular carcinoma in Qidong, China.

Wang SK, Wang ZZ, Lu XL, Wang Y, Jiang JD. Wang SK, et al. Among authors: jiang jd. Cancer Genet Cytogenet. 1999 Sep;113(2):191-2. doi: 10.1016/s0165-4608(99)00017-5. Cancer Genet Cytogenet. 1999. PMID: 10484991 No abstract available.

5

Low frequency of the ccr5delta32 HIV-resistance allele in mainland China: identification of the first case of ccr5delta32 mutation in the Chinese population.

Jiang JD, Wang Y, Wang ZZ, Chen XH, Guo ZM, Pan HL, Bekesi GJ, Wang AX, Chen HS. Jiang JD, et al. Scand J Infect Dis. 1999;31(4):345-8. doi: 10.1080/00365549950163752. Scand J Infect Dis. 1999. PMID: 10528870

6

Novel suicide ligands of tubulin arrest cancer cells in S-phase.

Davis A, Jiang JD, Middleton KM, Wang Y, Weisz I, Ling YH, Bekesi JG. Davis A, et al. Among authors: jiang jd. Neoplasia. 1999 Dec;1(6):498-507. doi: 10.1038/sj.neo.7900066. Neoplasia. 1999. PMID: 10935497 Free PMC article.

7

Antibody responses to HIV-1 antigens are higher in HIV-1(+) intravenous drug users than in HIV-1(+) homosexuals.

Jiang JD, Bekesi GJ. Jiang JD, et al. Biomed Pharmacother. 2001 Jul;55(6):313-5. doi: 10.1016/s0753-3322(01)00065-8. Biomed Pharmacother. 2001. PMID: 11478582

8

High anticancer efficacy of L-proline-m-bis (2-chloroethyl) amino-L-phenylalanyl-L-norvaline ethyl ester hydrochloride (MF13) in vivo.

Jiang JD, Zhang H, Li JN, Roboz J, Qiao WB, Holland JF, Bekesi G. Jiang JD, et al. Anticancer Res. 2001 May-Jun;21(3B):1681-9. Anticancer Res. 2001. PMID: 11497247

9

Double blockade of cell cycle at g(1)-s transition and m phase by 3-iodoacetamido benzoyl ethyl ester, a new type of tubulin ligand.

Jiang JD, Denner L, Ling YH, Li JN, Davis A, Wang Y, Li Y, Roboz J, Wang LG, Perez-Soler R, Marcelli M, Bekesi G, Holland JF. Jiang JD, et al. Cancer Res. 2002 Nov 1;62(21):6080-8. Cancer Res. 2002. PMID: 12414632

10

Inhibition of microtubule polymerization by 3-bromopropionylamino benzoylurea (JIMB01), a new cancericidal tubulin ligand.

Li JN, Song DQ, Lin YH, Hu QY, Yin L, Bekesi G, Holland JF, Jiang JD. Li JN, et al. Among authors: jiang jd. Biochem Pharmacol. 2003 May 15;65(10):1691-9. doi: 10.1016/s0006-2952(03)00101-1. Biochem Pharmacol. 2003. PMID: 12754105

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

387 results

Search Page

Filters